Skip to content

Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia

Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04829188
Acronym
ACCOMPLISH
Enrollment
1288
Registered
2021-04-02
Start date
2021-03-30
Completion date
2024-12-15
Last updated
2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Lower Resp Tract Infection, Pneumonia, Sepsis

Brief summary

An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.

Detailed description

This study implements an adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection and discharged to home (with or without a short stay in a skilled nursing facility prior to going home): structured telephone support (STS); low-intensity remote patient monitoring (RPM-Low); and high-intensity remote patient monitoring (RPM-High). The remote patient monitoring models will be staffed by a physician or a nurse (Standard Team) or by a dedicated nurse-practitioner (NP)-led multidisciplinary team (Enhanced Team). Patients will be randomized to one of five arms: STS, RPM-Low + Standard Team, RPM-Low + Enhanced Team, RPM-High + Standard Team, and RPM-High + Enhanced Team. Using response adaptive randomization (RAR), interim outcome results will be used to modify the random allocation of patients to each study arm. The primary outcome is number of days spent at home within 90 days after hospital discharge. Patient-reported functional status and quality of life data will be collected in addition to electronic health record (EHR) and claims-based data to measure health care utilization. Qualitative interviews with patients and providers will provide insight into the effectiveness of the implementation process.

Interventions

BEHAVIORALStructured Telephone Support (STS)

Structured telephone support (STS) consists of post-discharge assessment, education, and medication reconciliation delivered telephonically by a health plan case manager, home care as needed, and follow-up with the primary care within seven days post-discharge.

BEHAVIORALLow-intensity Remote Patient Monitoring (RPM-Low)

Questions are pushed to members multiple times per week for up to 90 days post-discharge. Questions are limited to those checking vital signs that indicate worsening of infection. Patient answers to RPM questions trigger High or Medium alerts, which trigger a response by members of the intervention care team.

BEHAVIORALHigh-intensity Remote Patient Monitoring (RPM-High)

Questions are pushed to members multiple times per week for up to 90 days post-discharge. Questions include monitoring vital signs for worsening infection but also ask about factors that would indicate worsening of underlying heart or lung conditions, such as weight gain or shortness of breath. Patient answers to RPM questions trigger High or Medium alerts, which trigger a response by members of the intervention care team.

BEHAVIORALStandard Response Team

RPM alerts are screened by a nurse-staffed call center. Nurses determine whether emergency care is needed. If not, nurses contact the patient and/or the patients' PCP or specialist to coordinate care and ensure timely follow-up.

BEHAVIORALEnhanced Response Team

RPM alerts are screened by a nurse-staffed call center. Nurses determine whether emergency care is needed. If not, the call center alerts a multidisciplinary care team that is led by a certified registered nurse practitioner (CRNP). CRNPs, who operate in a palliative care role, have prescribing authority and can modify care plans. In addition to reacting to RPM triggers, team members (e.g., CRNP, social workers, nurses) meet with the patient in-person or virtually in the week after discharge and at least twice more in the next 90 days, conduct assessments and a pharmacy review, develop care plans, and discuss advance directives.

Sponsors

Patient-Centered Outcomes Research Institute
CollaboratorOTHER
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* UPMC Health Plan members * Medicare Fee-for-Service enrollees * Age 21+ -Hospitalized with a primary diagnosis of sepsis or lower respiratory tract infection, -- * Discharged to home, independent living facility, or skilled nursing facility * Readmission risk is moderate or high

Exclusion criteria

* Admitted from hospice; * Discharged to hospice, inpatient rehabilitation, or a long term acute care facility; * Known to be pregnant; * Current enrollment in another remote patient monitoring program; * Failure of the Callahan 6 item cognitive screen and do not have a proxy to consent; * No access to a technological device required to participate in remote patient monitoring program; * Current enrollment in UPMC Advanced Illness Care program; * Severe, persistent cognitive impairment; * No documented PCP; * PCP disapproves of the patient being enrolled in remote patient monitoring; * Discharged from hospital to skilled nursing facility and stay at the skilled nursing facility for greater than 28 days

Design outcomes

Primary

MeasureTime frameDescription
Post-discharge home days90 days after discharge to homedays alive and at home

Secondary

MeasureTime frameDescription
Health-related Quality of Life (measured by Quality of Life Enjoyment and Satisfaction Questionnaire-SF)baseline, 90 daysHealth-related Quality of Life will be measured using the Quality of Life Enjoyment and Satisfaction Questionnaire-SF. The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) is a self-report measure designed to enable investigators to easily obtain sensitive measures of the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning. The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) is a 16 item self-administered questionnaire that captures life satisfaction over the past week. Each question is rated on a 5 point scale from 1 (Very Poor) to 5 (Very Good). A total score is derived from 14 items with a maximum score of 70 and with higher scores indicating greater life satisfaction and enjoyment.
Transition to Hospicemeasured at 90 days after discharge to homeTransition to Hospice will be assessed via health insurance claims.
Functional Status (measured by PROMIS Physical Function-for Mobility Aid Users-SF)baseline, 90 daysFunctional Status will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function - for Mobility Aid Users-SF. This measures one's ability to stand, walk, and perform activities of daily living if some participants utilize mobility aids such as wheelchairs. The minimum score for patients who can walk 25 feet is 11 and the maximum 55. The minimum score for patients who cannot walk 25 feet is 8 and the maximum score is 40. Higher scores indicate better function status for both groups.
Hospital readmissionsmeasured at 7 daysReadmissions will be assessed via health insurance claims for any inpatient admissions after index admission.
Mortalitymeasured at 90 daysMortality will be assessed via claims data to see if and when the member/participant passes away.
Emergent outpatient utilizationmeasured at 90 days after discharge to homeEmergent outpatient utilization includes emergency department visits and urgent care visits. It will be assessed via claims data at 90 days for study participants.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026